MDxHealth S.A. (MDXH) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 6 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for MDXH is $15.00, representing a +560.8% upside from the current price of $2.27. Price targets range from a low of $15.00 to a high of $15.00.
